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Mitochondrial importAs a signaling scaffold, p62/sequestosome (p62/SQSTM1) plays important roles in cell signaling and degrada-
tion of misfolded proteins. While localization of p62 to mitochondria has been reported, a description of its
function once there, remains unclear. Here, we report that p62 is localized to mitochondria in non-stressed
situations and demonstrate that deﬁciency in p62 exacerbates defects in mitochondrial membrane potential
and energetics leading to mitochondrial dysfunction. We report on the relationship between mitochondrial
protein import and p62. In a p62 null background, mitochondrial import of the mitochondrial transcription
factor TFAM is disrupted. When p62 is returned, mitochondrial function is restored to more normal levels.
We identify for the ﬁrst time that p62 localization plays a role in regulating mitochondrial morphology, ge-
nome integrity and mitochondrial import of a key transcription factor. We present evidence that these re-
sponses to the presence of p62 extend beyond the protein's immediate inﬂuence on membrane potential.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Sequestosome 1/p62 was identiﬁed as a ubiquitin binding protein
[1], and has been localized to aggresomes of various neurodegenera-
tive diseases [2]. p62 plays critical roles in neurodegeneration, cancer,
and obesity through regulation of cell signaling, protein degradation
and NF-κB activation [3–5]. p62 contains several interaction motifs
that endow the protein with scaffolding abilities [3] and is important
in both the UPS and autophagy degradation pathways. In the UPS,
p62 interacts with polyubiquitinated proteins through its C-terminal
UBA domain allowing shuttling to the proteasome for degradation
[6]. Mediation of autophagy occurs by p62 polymerizing through an
N-terminal PB1 domain and interaction with the autophagic marker
protein LC3 [7,8]. p62 itself is degraded by autophagy with autophagic
defects causing accumulation of p62 in response to stress stimuli [9].
Inability to clear p62-containing aggregates increases ROS levels,
DNA damage, tumorigenesis and cell death in the absence of autoph-
agy [10,11].
Growing lines of evidence correlate p62 with clustering of dam-
aged mitochondria. p62 is recruited to depolarized mitochondria in
PINK1/parkin-expressing cells, two proteins linked to the pathology
of Parkinson's disease (PD) [12]. Efﬁcient mitochondrial function
and turnover depends on continuous structural remodeling throughrtment of Biological Sciences,
826; fax: +1 334 844 9234.
n).
l rights reserved.fusion and ﬁssion [13]. Daughter mitochondria produced by ﬁssion
can either maintain intact membrane potential or become depolar-
ized. Depolarizedmitochondriamay restore theirmembrane potential
and return to normal fusion/ﬁssion equilibrium or remain as non-
fusing mitochondria to be eliminated by autophagy. It has been pro-
posed that ﬁssion acts as an autophagic checkpoint [14]. Depolarized
mitochondria change their morphology to a more fragmented form
and show perinuclear clustering (“mito-aggresomes”). Completion
of the mitophagy pathway appears to be dependent on the recruit-
ment of both p62 and HDAC6 [12,15]. Although there are conﬂicting
reports as to p62's role in mitophagy, it is known to be indispensable
in the polymerization and transportation of mitochondria to aggre-
gates [16,17]. This diverse suite of p62 functions is known to take
place under stress or pathological conditions. However, whether p62
is localized to mitochondria and what its function might be under
physiological conditions remains unclear.
The structural state of mitochondria is directly related to the
organelle's functional status [18]. Mitochondrial fragmentation corre-
lates with bioenergetic defects and elevated oxidative stress leading
to increased mtDNA mutations [19–21]. Meanwhile, mitochondrial
fusion is required for mtDNA stability in skeletal muscle and protects
against neurodegeneration in the cerebellum [22]. Disruption of fu-
sion leads to loss of membrane potential and decreased cellular respi-
ration [19]. Defects in mitochondrial dynamics causing dysfunction
have been linked to multiple neurodegenerative diseases [23].
The mitochondrial genome encodes rRNAs, tRNAs and proteins
important for cell respiration and ATP generation [24,25]. mtDNA is
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chondria being the major source of ROS, a lack of histone protection
in mtDNA and reduced mitochondrial DNA repair ability. mtDNA
damage results in decreased membrane potential (Δψm), increased
apoptotic cell death [26], and is a hallmark of neurodegenerative
diseases [27,28]. Depletion of mtDNA can result in mitochondrial
change, such as fragmentation and reduction in number of cristae
[29]. Thus, maintenance of the mitochondrial genome is crucial for
cell survival.
Our previous studies revealed that p62 protected cells from oxida-
tive damage and promoted cell survival while defects in p62 resulted
in oxidative damage to nuclear DNA in association with various neu-
rodegenerative diseases [30,31]. In the current study, the relationship
between p62 and mitochondrial dynamics was investigated using
p62−/− tissues and cells. p62−/− mice possess an AD-like phenotype
[32] and exhibit mitochondrial morphology and mtDNA damage as-
sociated with neurodegenerative diseases. Our goal was to elucidate
the relationships between p62, mtDNA stability and biosynthesis.
We also wished to examine how p62 might affect mitochondrial mor-
phology and function. We show for the ﬁrst time that p62 plays a role
in maintaining functional mitochondrial energetics and is integral for
increased mtDNA stability.
2. Materials and methods
2.1. Reagents and antibodies
All chemicals in this project were obtained from Sigma (St. Louis,
MO). Lipofectamine 2000 transfection reagent and ATP synthase anti-
body were from Life Technologies (Carlsbad, CA). p62 antibody was
from ABCAM (Cambridge, MA). All other antibodies were from Santa
Cruz (Santa Cruz, CA).
2.2. Cell culture and transfection
WT and p62−/−Mouse Embryonic Fibroblast (MEF) cells were cul-
tured in DMEMmedia with 10% fetal bovine serum and pen/strep in a
37 °C incubator in 5% CO2. Cells were transfected using Lipofectamine
2000 transfection reagent in OPTIMEM media as directed in reagent
insert for a total of 48 h prior to harvest.
2.3. Western blot and analysis
The cell lysate or isolatedmitochondriawas subject to SDS-PAGE in
polyacrylamide gels. Samples were Western blotted with primary an-
tibody from sources described above and HRP-tagged secondary anti-
body from GE Healthcare Life Sciences (Pittsburgh, PA) and processed
with ECL detection reagent. Following exposure of the labeled mem-
brane to Hyperﬁlm-ECL detection ﬁlm, the Un-Scan-it Gel and Graph
Digitizing software (Silk Scientiﬁc, Orem, UT) was used to scan and
quantify the signal from theWestern blot, and datawere analyzed sta-
tistically (Win-SAS, Microsoft, Seattle, WA).
2.4. Mitochondrial isolation
Following trypsinization, MEF cells were collected by centrifugation
andmitochondria isolated essentially as described byWieckowski et al.
[33]. Brieﬂy,washed cells were homogenized on icewith a Teﬂon pestle
followed by centrifugation twice at 600×g for 5 min. The Post Nuclear
Pellet (PNP) was collected from the pellets and the supernatant was
centrifuged at 7000 ×g for 10 min. The cytosolic fraction (Cyto) was
obtained from the supernatant while the crude mitochondrial pel-
let (C. Mito) was collected in the pellet. The pellet was washed with
MRB buffer (250 mM mannitol, 5 mM HEPES, pH 7.4 and 0.5 mM
EDTA) before being layered over a Percol gradient. The gradient was
centrifuged at 95,000 ×g for 30 min with a dense band containingpuriﬁed mitochondria localized at the bottom of the tube. This band
was collected and washed with MRB buffer before being suspended in
a small volume of MRB buffer containing protease inhibitors. Protein
concentrationwas determined by Bradford assay (Bio-Rad Laboratories,
Hercules, CA) and subjected to SDS-PAGE and Western blot or used in
further experiments as mitochondrial lysates.
2.5. Immuno-electron microscopy
Immuno-TEM was performed essentially as described by Liu et al.
[34]. Brieﬂy, mitochondria were isolated as by Percol gradient cen-
trifugation, collected in homogenization buffer and ﬁxed by addition
of 4% formaldehyde, 0.4% glutaraldehyde, and 4 mM CaCl2 in 0.1 M
cacodylate buffer, pH 7.3. Mitochondrial pellets were collected and
washed with 0.1 M cacodylate/2 mM CaCl2 prior to embedment in
LRWhite (EMS). Sections (~80 nm) were collected to 300 mesh nick-
el grids and etched with saturated sodium periodate (Sigma) prior to
blocking with 4% acetylated BSA in Tris buffered saline. Grids were in-
cubated with SQSTM1/p62 antibody (1:100) in 1% Ac-BSA/TBS over-
night at 4 °C followed by goat-anti-rabbit conjugated with 20 nm
colloidal gold (EMS) for 1 h at room temperature. Sections were post-
ﬁxed in 2% glutaraldehyde, rinsed in distilled water and contrasted
with 2% uranyl acetate and lead citrate.
2.6. Immunocytochemistry
For immunocytochemical analysis, MEF cells or other cells as indi-
catedwere grown on coverslips in 24-well plates in DMEM, andwhere
indicated, transfected with myc-p62 plasmid. Cells were stained with
MitoTracker Red (Life Technologies, Grand Island, NY) prior to ﬁxation
with warm 4% PFA in PBS and permeabilized with 0.1% TX-100 for
10 min. The cells were subsequently blocked in 3% nonfat dry milk
in PBS and incubatedwith primary antibody overnight at 4 °C, washed
and incubated with secondary antibody coupled to FITC (Invitrogen,
Carlsbad, CA) in blocking buffer for 2 h. After washing in PBS, the cov-
erslips were mounted on slides using Vectashield Hardset Mounting
media (Vector Laboratories, Burlingame, CA), and analyzed using a
Zeiss Axiovert ﬂuorescent microscope with Zeiss PLAN-Apochromatic
63× 1.4 Oil DIC lens. Images were collected and magniﬁed with NIS-
Elements AR software (Nikon, Melville, NY). Representative images
are shown for all ﬂuorescent applications from an approximate pool
of 100 cells analyzed. Mitochondrial morphologies were quantitated
in a blinded study as described in ﬁgure legends.
2.7. mtDNA copy number and oxidative damage of mtDNA
Genomic DNA was isolated from brain tissue using the DNeasy
Tissue Kit (Qiagen, Valencia, CA). Following elution with ddH2O, puri-
ﬁed DNA was stored at −80 °C. Relative Quantitative real time PCR
was employed to determine mtDNA copy number. mtDNAwas ampli-
ﬁed with mtDNA primer: MDF: 5′-CCTATCACCCTTGCCATCAT-3′ and
MDR: 5′-GAGGCTGTTGCTTGTGTGAC-3′. Nuclear DNA was ampliﬁed
by nuclear DNA primer: NDF: 5′-ACATCTGTTGCTCCGGCTCTCATT-3′
and NDR: 5′-GCAAGCTCAAAGGGCAAGGCTAAA-3′. RT-QPCR was con-
ducted using an ABI 7500 Real Time PCR system (Applied Biosystems,
Carlsbad, CA) using Power SYBR Green PCR Master Mix. Relative
mtDNA levels were calculated by the ΔΔCt method as described
(Acevedo-Torres et al., DNA Repair 8:126). Larger 10 kb fragments
were ampliﬁed by GeneAmpXL PCR kit (Applied Biosystems, Carlsbad,
CA) using the primer set: mt5733F: 5′-CCAGTCCATGCAGGAGCATC-3′
and mt15733R: 5′-CGAGAAGAGGGGCATTGGTG-3′. A small 91 bp
fragment was ampliﬁed by primer set: Mt13597F: 5′-CCCAGCTACTA
CCATCATTCAAGT-3′ and Mt13688R: 5′-GATGGTTTGGGAGATTGGTTG
ATGT-3′. Aliquots of the 10 kb PCR products were resolved on 0.8% aga-
rose gels, while 91 bp PCR products were resolved on a 2% agarose gel.
Density of bands were scanned and quantiﬁed. Relative ampliﬁcations
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average lesion frequency per 10 kb (λ) was calculated as λ=ln AD/AO.
2.8. ATP assay
ATP production was measured using the ATP Determination Kit
(Life Technologies, Grand Island, NY). Brieﬂy, MEF cells were detached
from tissue culture plates by trypsin treatment and collected by brief
centrifugation followed by PBS wash. Cell pellets were resuspended
in isolation buffer (5 mM HEPES, pH 7.2; 225 mM mannitol, 75 mM
sucrose, 1 mM EGTA, and protease inhibitors) followed by 5 times sy-
ringe using a 23 gauge needle. Samples were centrifuged at 1500 ×g
for 5 min prior to supernatants being used for ATP assay following
the manufacturer's directions and measured with a luminometer.
Each sample was measured in triplicate.
2.9. ROS assay
ROS levels were measured using the ﬂuorogenic dye H2DCFDA
(Life Technologies, Grand Island, NY). MEF cells were grown in 24
well tissue culture plates. Growth media was removed from attached
cells and replaced with fresh DMEMmedia prior to treatment directly
into the media with 10 μMH2DCFDA. Fluorescence was measured im-
mediately post stain addition (T=0 min) and again at T=30 min.
H2DCFDA interacts with ROS produced in living cells and released
into the culture media showing an increase in ﬂuorescence when ex-
cited at 485 nm and measured emission at 528 nm.
2.10. Membrane potential assay
Brieﬂy, cells were grown in DMEM media and harvested following
trypsinization. Cells werewashed and resuspended inmedia containing
5 μM JC-1 followed by incubation at 37 °C for 30 min. Cells were
pelleted and washed with PBS, resuspended in PBS and counted with
an Accuri C6 Flow Cytometer. JC-1 ﬂuorescence was measured in FL1
(530 nm) and FL2 (585 nm) channels with 50,000 events captured.
2.11. Statistical analyses
Data were expressed as the mean±SEM of different groups. Pos-
sible differences between group means and statistical signiﬁcance be-
tween WT and p62−/− MEF cells or mice were analyzed using one
way ANOVAs (SAS v9.2, SAS Institute Inc.). For signiﬁcant differences,
alpha was set at 0.05.
3. Results and discussion
3.1. p62 localizes to mitochondria under physiological conditions
Mitochondrial dysfunction is amajor characteristic of neurodegen-
erative disease, cancer and obesity [35,36]. p62 is known to be
mitochondrially associated under stress conditions [12], including ox-
idative stress [37]. Correlatively, our research has shown that absence
of p62 results in higher oxidative damage in mouse cells and tissues
[31]. We reasoned that these two observations were interrelated,
and thus sought to examine if p62 plays an undiscovered role in mito-
chondrial function and oxidative metabolism. Using embryonic ﬁbro-
blasts, we ﬁrst investigated whether p62 localized to mitochondria
under physiological conditions in our model system. Mitochondrial
fractions were isolated fromWT and p62−/−MEF cells and subjected
toWestern blot analysis. Mitochondrial and organellemarker proteins
were used to determine the purity ofmitochondrial fractions (Fig. 1A).
Mitochondrially associated proteins were detected predominantly in
mitochondrial fractions while cellular markers were effectively limit-
ed to pre-fractionated lysate or cytoplasmic fractions. One notable ex-
ception was the ER protein calnexin found in crude mitochondrialfractions of both WT and p62−/− samples. This is likely due to the in-
timate association ofmitochondriawith ER [38,39]. However, calnexin
was absent from further puriﬁedmitochondrial fractions. Endogenous
p62 distribution was also examined and a pool of endogenous pro-
tein was found to be localized to puriﬁed mitochondria of WT MEF
cells under physiological conditions while the absence of p62 from
p62−/− cells was also conﬁrmed (Fig. 1A).
Mitochondrial localization of p62 was visualized by immuno-
ﬂuorescence and immuno-TEM. WT MEF cells were treated with
MitoTracker Red prior to ﬁxation and immunostaining for endogenous
p62. Using FITC-labeled secondary antibody, unstimulated pools of
p62were found associatedwithmitochondria (Fig. 1B). Colocalization
was quantitatively estimated using the NIS Elements software
(Nikon). A Mander's Overlap Coefﬁcient value [40] of 0.749 was ob-
tained suggesting colocalization of p62 with the mitochondria. Fur-
ther, mitochondria isolated from WT MEFs followed by immuno-
TEM with p62 antibody (Fig. 1C) showed labeling not only localized
to the outer mitochondrial membrane (OMM) but was also observed
associated with the inner mitochondrial membrane (IMM). These
data indicate that p62 could be found inside, as well as on the surface
of mitochondria. These results are consistent with recent reports that
portions of mitochondrially localized p62 are protected from protein-
ase K digestion [37]. It is possible p62 localization spans all mitochon-
drial compartments and plays a similar role as the ATPase ATAD3A
which speciﬁcally functions to regulate mitochondrial dynamics [41].
3.2. Localization of p62 to the mitochondria affects mitochondrial
morphology
Since p62 localized to mitochondria and mitochondrial shape or-
chestrates mitochondrial function [18], we asked if p62 localiza-
tion could affect mitochondrial morphology. Using a variety of cell
types, plus or minus p62, we examined mitochondrial structure by
MitoTracker Red staining. We found that the morphology of mito-
chondria, irrespective of cell type, became fragmented in the absence
of p62 (Fig. 2A). Mitochondrial structure was individually quantitated
showing an increase in fragmented morphology in the absence of p62
while a normal “tubular-like” mitochondrial structure was seen in
WT cells consistently across cell types.
We next reasoned that if removal of p62 results in mitochondrial
fragmentation, restoring p62 to p62−/− cells could rescue mitochon-
drial morphology. p62−/− MEFs were transfected with myc-tagged
p62, mitochondria stained with MitoTracker Red and immuno-
stained for tagged p62. Only cells showing immunoﬂuorescence for
FITC-myc, indicating successful introduction of exogenous p62, were
used in the analysis. When myc-p62 was introduced, mitochondrial
morphology did revert to a ribbon-like tubulo-reticular network in-
dicative of normal mitochondria. (Fig. 2B). These results suggest
that morphological changes in mitochondria may be directly correlat-
ed with mitochondrial localization of p62. Fragmentation is directly
associated with mitochondrial depolarization and energetics defects
[42]. Since p62 localizes to mitochondria, restores normal mitochon-
drial morphology and possibly spans the mitochondrial membranes
[37], we reasoned that p62 could be in a position to affect mitochon-
drial depolarization and energetics.
3.3. p62 is required for normal mitochondrial function
Growing lines of evidence show a positive correlation betweenmi-
tochondrial fragmentation and loss of membrane potential, decreased
mitochondrial energetics, andmtDNA damage response [19,24,26,29].
Based on initial observations of atypical mitochondrial morphology in
p62−/− cells, we anticipated elevated mitochondrial dysfunction and
genomic instability. In order to evaluate if p62−/−mitochondrial mor-
phology correlated with mitochondrial energetics, we examinedΔψm
in WT and p62−/− cells by staining with JC-1. JC-1 selectively enters
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ﬂuorescence when examined by ﬂow cytometry (Fig. 3A) indicating
a signiﬁcant portion of the mitochondria displayed decreased mem-
brane potential when compared to WT cells. Defects in Δψm have
been shown to negatively impact mitochondrial dynamics and energy
production [43], therefore, we sought to examine if p62 might play a
role in maintaining functional mitochondrial energetics.M
EF
N
eu
ro
n
As
tro
cy
te
WT KOA
0
20
40
60
80
100
0
20
40
60
80
100
0
20
40
60
80
100
WT    
Ce
ll n
u
m
be
r (
% 
To
ta
l)
Fig. 2. p62 regulates mitochondrial morphology autonomous of cell type. (A) p62−/− cell type
Red staining. Morphology was classiﬁed as tubular (black bar), fragmented (gray bar) or in
of 100 cells were classiﬁed for each cell type. (B) p62−/−MEF cells were transfected with my
exhibiting expression of FITC-myc-p62 were used in the analysis. Inset shows FITC-myc-p62
in (A). Data for all graphs are mean±s.e.m., Pb0.05.To address p62 effects on energy production, we measured the ca-
pacity of mitochondria to synthesize ATP in MEF cells plus or minus
p62. Signiﬁcant impairment in ATP production was observed in
p62−/− cells cultured in DMEMmediawith glucose as themajor ener-
gy substrate suggesting p62 is required for normal cellular energetics
through glycolysis (Fig. 3B). When cells were cultured in glucose free
media containing galactose as the energy source to forcemitochondri-
al respiration, ATP levels were likewise depressed in the absence ofB
0
20
40
60
80
100
0
20
40
60
80
100
    KO
Ce
ll n
u
m
be
r (
% 
To
ta
l)
s were compared to WT for mitochondrial morphology and visualized by MitoTracker
termediate (white bar) and cells counted in each class. Mitochondria from a minimum
c-p62 to analyze reversion of mitochondrial phenotype. For transfected cells, only those
immunoﬂuorescence for represented cell. Mitochondria were classiﬁed and counted as
WT
KO
KO+myc-p62
0 30 min
0.5
1.0
20
0
40
60
0.0
-0.5
0
*
WT KO
A
B
C
D
R2 R2R3 R3
R4 R4R5 R5
28.2% 62.9%
42.9% 19.3%
24.6% 1.5%
P1 P1
P2 P2
P3 P3
100 100
100
101 101
101
102 102
102
103 103
103
104 104
104
FL-1 log FL-1 log
FL
-2
 lo
g
WT KO
WT KO KO
+myc-p62
0
40
80
120
160
200
D D DG G GG/O G/O G/O
AT
P 
(nM
) / 
  g
 pr
ote
in
O
xid
at
ive
 D
am
ag
e
(le
sio
ns
/10
Kb
)
Ab
s 
(52
8n
m)
/  g
Fig. 3. Abnormal mitochondrial metabolism and increased oxidative stress in p62−/− cells. (A) Membrane potential was analyzed using JC-1 staining in WT or p62−/−MEF cells. Cells
were counted by ﬂow cytometry. (B) Mitochondrial ATP production inWT and p62−/−MEF cells minus/plus exogenous myc-p62. Cells were grown in DMEM (D), galacotose media
(G) or galactose media plus oligomycin (G/O). (C) WT or p62−/− MEF cells minus/plus exogenous myc-p62 were analyzed for ROS production by detection with H2DCFDA at
485 nm at times indicated. (D) Comparison of the oxidative damage of mitochondrial DNA fragments in WT and p62−/− mice. Data for all graphs are mean±s.e.m., Pb0.05.
456 M.L. Seibenhener et al. / Biochimica et Biophysica Acta 1833 (2013) 452–459p62.We did not observe an increase in ATP productionwhen ATP syn-
thase was inhibited with oligomycin seemingly indicating that the
lack of p62 does not cause reversal of ATP synthase [44,45]. Moreover,
the decrease in ATP production was abrogated when p62 was intro-
duced into a null background showing that ATP production can be res-
cued by p62 restoration. Glucose tolerance tests in aged p62−/−mice
have also shown to be defective in glucose uptake and insulin toler-
ance [4] indicative of glycolytic defects. Interestingly, overexpression
of p62 not only recovered ATP production to WT levels, but also ap-
peared to increase overall ATP levels above control (Fig. 4B). While
decreased Δψm of p62−/− MEFs no doubt affects ATP levels in mito-
chondria, restoration of ATP above WT levels seems to be a clear indi-
cation that the presence of p62 is integral tomitochondrial energetics in
a manner that extends beyond simply impacting membrane potential.
Changes in Δψm are initiating events during activation of NADPH
oxidase and ROS production [46]. We reasoned that decreased Δψm
of p62−/− MEFs along with deregulation of OXPHOS would result in
an increase in ROS production [47]. Indeed, analysis of ROS from cul-
ture media of WT and p62−/− MEFs showed increased levels in
p62−/− MEFs which was again abrogated with the addition of p62
(Fig. 3C). mtDNA damage is a hallmark response to ROS-induced ox-
idative stress [48]. p62 has been shown to protect nuclear DNA from
oxidative damage [31]. We therefore hypothesized that p62's associ-
ation with mitochondria could also confer protection to mtDNA. To
evaluate this possibility, we examined damage to mtDNA in the hip-
pocampus of WT and p62−/− mice. We observed an increase in in
vivo oxidative damage from mtDNA fragments from p62−/− mice
(Fig. 3D). Similar results have been seen in p62's role in the Keap1–
Nrf2–Nqo1 pathway and mitochondrial aging [49]. Consequently,
the observed correlation between elevated ROS levels and increased
mtDNA damage in the absence of p62 as well as the fact that p62
can abrogate the effects of mtDNA damage in a null background was
consistent with our hypothesis that p62 plays a general role in medi-
ating oxidative stress. Furthermore, ROS acts as a key modulator ofmtDNA copy number [50] while oxidative stress promotes mitochon-
drial ﬁssion in neurons [13]. Overall, our results indicate that a deﬁ-
ciency in p62 could be an underlying cause of increased oxidative
stress related damage to mtDNA.
3.4. p62 is integral to maintaining mitochondrial stability and mtDNA
biogenesis
Normal mitochondrial dynamics maintain mtDNA copy number
while fragmentation results in mtDNA mutations and loss of mtDNA
[13,22]. In addition to mtDNA damage, total quantity of mtDNA is
reported to regulate energy metabolism [24]. We investigated if loss
of p62 affected the physical volume of the mitochondrial genome
pool in p62−/− mice. We examined total DNA copy number in mito-
chondria from brain of age matched WT and p62−/− mice (Fig. 4A).
mtDNA copy number accumulated with age, peaking at 12-months
in both genotypes. Increased levels of mtDNA have been observed in
both human and mouse brain tissue previously [51,52] possibly due
to a p62 dependent role in mitophagy [16]. However, p62−/− consis-
tently measured belowWT levels after 3 months of age. In order to in-
vestigate if mtDNA variation was tissue speciﬁc, we also examined
mtDNA copy number in mouse liver and adipose tissues at 9 months
(Fig. 4B). Decreases in mtDNA levels were seen in both tissues indicat-
ing that loss of mtDNA copy number in p62−/−mice could be univer-
sal. mtDNA copy number of p62−/−mice decreased compared to age-
matched WT mice which correlates with the appearance of early AD
phenotypes [32]. This result is consistent with investigations that pro-
pose mtDNA decrease occurs as an early event preceding loss of mito-
chondrial function [27,53,54].
Loss of copy number was further seen in p62−/− MEF cells where
mtDNA levels decreased compared with WT cells (Fig. 4C). Of note,
when p62 was introduced to p62−/−MEF cells, mtDNA levels returned
to a point consistent with WT whereas overexpression of p62 in WT
cells resulted in a 3-fold increase in mtDNA. This is signiﬁcant in that
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type of p62−/− MEFS, but overexpression also increased the levels of
mtDNA in normal cells. mtDNA levels are correlated with functional
energetics [24] and our data demonstrate that the presence of p62 is re-
quired for normal mitochondrial energy production (Fig. 3B). Collec-
tively, our results lead to the unequivocal conclusion that p62 plays a
central role in mitochondrial biogenesis and mitochondrial energetics.
The full magnitude of this observed p62/mitochondria association re-
mains largely unexplored and presents a fertile area for subsequent
research.
One aspect of the p62/mitochondria relationship we investigated
was related to the observation of a physical association between
p62 and mitochondrial membranes. p62 has been shown to be a com-
ponent of the nuclear pore complex, directly implicating it in protein
import [55]. Recently, parkin was reported to protect the mitochon-
drial genome by association with mitochondrial transcription factor
A (TFAM) prior to its import into mitochondria [56,57]. TFAM pro-
motes mtDNA replication/transcription [58], protects mtDNA from
damage [59,60] and affects repair of oxidatively damaged mtDNA
[59,61]. Moreover, replication of mtDNA is dependent on TFAM im-
port and activated transcription [62]. As levels of mtDNA were re-
stored in p62−/− cells and increased in WT cells overexpressing
p62, we reasoned that p62 might play a role in TFAM/mitochondria
association and import. Such a relationship might represent one ave-
nue by which p62 contributes to stabilized energetics and protection
of the mitochondrial genome.We isolatedmitochondria fromWT andp62−/− MEF cells and analyzed levels of TFAM protein (Fig. 4D). WT
cells showed signiﬁcantly more mature TFAM localized into the mito-
chondria than did p62−/− MEFs while mitochondrial protein TOM40
remained relatively unchanged. Interestingly, this correlates well
with the levels of mtDNA observed in Fig. 4C indicating TFAM tran-
scriptional activity is not affected. When myc-p62 constructs were
expressed to increase p62 levels, a noticeable increase in TFAM pro-
tein was detected in WT mitochondria while restoration of p62 in
p62−/− MEFs increased TFAM in the mitochondria to levels ap-
proaching WT basal expression. Post-translational modiﬁcation
(maturing) of TFAM occurs following import into mitochondria [63],
thus increases in mature TFAM protein in transfected p62−/− MEFs
provide clear evidence that mitochondrial import was restored.
A direct correlation between TFAM and mtDNA copy number has
been seen in multiple systems [58,59,64]. Moreover, decreased
mtDNA levels and respiratory chain function were found in TFAM−/−
adipose cells [65]. We demonstrated a decrease in mitochondrial
TFAM protein levels along with associated energetic defects and de-
creased mtDNA copy number in p62−/− MEFs. Expression of p62 in a
null background system effectively restores mitochondrial energetics,
in many instances approaching WT levels. Our data also indicated that
while restoring p62 expression resulted in normal levels of mitochon-
drial import, overexpression of p62 increased TFAM import into mito-
chondria resulting in higher levels of total mtDNA. This indicates p62
is integral to maintaining normal mitochondrial function and bio-
genesis. The exact in vivo import mechanism is yet unknown but the
458 M.L. Seibenhener et al. / Biochimica et Biophysica Acta 1833 (2013) 452–459evidence indicates it is multifactorial. Lack of p62 obviously results
in decreased Δψm (Fig 3A). Variation in membrane potential is
well known to directly affect import dynamics [66] and therefore no
doubt accounts for some proportion of the observed p62/TFAM import
relationship. But importantly, based on increased levels of TFAM in
mitochondria as well as the increase in total mtDNA from p62 over-
expressed cells, p62 plays an important, independent role in the func-
tionality of normal mitochondrial dynamics which extends beyond
solely altering Δψm.
4. Conclusion
In conclusion, our study not only conﬁrmed that p62 localizes to
the mitochondria under non-stressed, physiological conditions but
also further deﬁnes a critical role for p62 in the normal functioning
of mitochondria. We show that p62 is integral to normal mitochon-
drial dynamics and, by regulation of the mitochondrial transcription
factor TFAM, maintains mitochondrial genome stability. These func-
tions appear to be the results of direct interactions of p62 with mito-
chondria that extend beyond generalized physiological responses.
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